| ||
| HP climbs, NetApp tumbles in after hours trade MarketWatch Joining NetApp in the red were shares of MediciNova Inc. (US:MNOV) after the biopharma company said a clinical study of its MN-221 asthma treatment didn't yield statistically significant results. The shares fell 47% to $1.46 in modest volume. See all stories on this topic » | ||
| Predicting Response to Therapy in Mild Persistent Asthma Newswise (press release) "We performed post-hoc data analysis on 288 children enrolled in the TReating Children to Prevent Exacerbations of Asthma (TREXA) study performed by the NHLBI funded Childhood Asthma Research and Education (CARE) Network," said Lynn Gerald, PhD, MSPH, ... See all stories on this topic » |
| ||
| Dr. Alle Goes to Washington - - Allergy and Asthma Care Centers She found herself on the frontlines of the battle over allergy and asthma treatment . This year's debate centers on a drug proposal issued by the Food and Drug ... www.myallergycare.com/.../dr-alle-goes-to-washington-it-was-... | ||
|
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment